The multifaceted role of IL-12 in cancer
Authors:
- Um e HabibaUHUm e Habiba
- Mussarat RafiqMRMussarat Rafiq
- Muhammad Babar KhawarMKMuhammad Babar Khawar
- Bismillah NazirBNBismillah Nazir
- Gulfam HaiderGHGulfam Haider
- Nadia NazirNNNadia Nazir
Open Access
- 25 June 2022
- journal article
- research article
- Published by Elsevier in Advances in Cancer Biology - Metastasis
- Vol. 5
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsJournal of Clinical Investigation, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12Journal of Immunotherapy, 2010
- The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesProceedings of the National Academy of Sciences, 2009
- Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate DeterminationImmunity, 2008
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- Interleukin-12: A master regulatorJournal of Experimental Medicine, 2007
- Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic miceVaccine, 2003
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992
- The Role of Interferon in Cancer Therapy: A Current PerspectiveCA: A Cancer Journal for Clinicians, 1988